Human Relations - Protection of the Free Exercise of Religion
HB 356 revises Maryland’s retiree prescription drug benefit structure for State employees and retirees. The bill would allow certain retirees who began State service before July 1, 2011 to remain eligible for State prescription drug benefits in the State Employee and Retiree Health and Welfare Benefits Program, while discontinuing those benefits for Medicare-eligible retirees who began State service on or after that date, along with their Medicare-eligible spouses and dependent children. It also repeals several existing statutory programs created in 2019 that were designed to provide separate prescription drug reimbursement assistance to retirees after the State’s transition away from direct drug coverage for Medicare-eligible retirees.
The bill amends § 2-509.1 of the State Personnel and Pensions Article and repeals provisions of Chapter 767 of the Acts of 2019. In practical terms, it would change which retirees receive State-sponsored prescription drug coverage versus Medicare-based coverage and would eliminate the statutory framework for the Maryland State Retiree Prescription Drug Coverage Program, the Catastrophic Prescription Drug Assistance Program, and the Life-Sustaining Prescription Drug Assistance Program. The bill also removes related notice, reporting, counseling, and implementation requirements that were tied to those repealed programs.
Its impact on state law is significant for retiree health benefits administration. The Department of Budget and Management would no longer be required to operate or report on the repealed assistance programs, and the State would continue coverage only for the retiree groups expressly preserved by the amended statute. The bill would therefore affect State retirees, surviving spouses, dependent children, and the agencies responsible for administering retiree health benefits and communicating Medicare-related options.
Because no committee transcript or vote record is provided, the available context does not show direct debate or recorded support/opposition. Based on the bill text, the measure appears to be a policy reset around retiree prescription drug benefits, with a clear administrative simplification component. The main point of likely contention is the treatment of Medicare-eligible retirees hired on or after July 1, 2011, who would lose State prescription drug benefits, versus retirees hired earlier who would retain access; that distinction could be viewed as a cost-saving change by supporters and a benefit reduction by opponents.
HB 356 would amend Maryland’s State Personnel and Pensions law to narrow State prescription drug benefits for retirees and repeal several 2019 statutory programs that provided reimbursement-based assistance to Medicare-eligible retirees. It would shift the legal framework away from the existing State retiree drug assistance programs and remove associated notice, reporting, counseling, and implementation mandates for the Department of Budget and Management. The bill primarily affects State retirees, their spouses, surviving spouses, and dependent children, as well as the agencies administering retiree health benefits.
No committee testimony or vote history is included, so there is no documented public sentiment in the provided materials. From the bill’s structure, the measure appears to be a targeted administrative and benefit-eligibility change rather than a broad policy expansion. The text suggests a likely split between those favoring simplification and reduced State obligations and those concerned about reduced prescription drug support for certain retirees.
The central point of contention is the bill’s differential treatment of retirees based on when they began State service. Retirees who began service on or after July 1, 2011 and are Medicare-eligible would lose State prescription drug benefits, while earlier retirees would remain eligible. Another likely issue is the repeal of the existing reimbursement and assistance programs, which may be viewed as eliminating a safety net for retirees facing Medicare drug costs. The Department of Budget and Management would also no longer have the same statutory duties to provide notices, counseling, and reports, which could draw concern from retirees and advocates for benefit continuity.